Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy

Author： Coleman Suzanne   Wallace Lisa   Alexander Jeffrey   Istwan Niki  

Publisher： Informa Healthcare

ISSN： 1476-4954

Source： Journal of Maternal-Fetal and Neonatal Medicine, Vol.25, Iss.7, 2012-07, pp. : 1034-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate*

By Timofeev Julia   Feghali Maisa   Boyle Annelee   Istwan Niki   Rhea Debbie   Driggers Rita W.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 9, 2013-06 ,pp. : 881-884

Informa Healthcare

Access to resources Recommend Favorite

Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate

By Szychowski Jeff M.   Berghella Vincenzo   Owen John   Hankins Gary   Iams Jay D.   Sheffield Jeanne S.   Perez-Delboy Annette   Wing Deborah A.   Guzman Edwin R.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 12, 2012-12 ,pp. : 2686-2689

Informa Healthcare

Access to resources Recommend Favorite

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate

By Durnwald Celeste P.   Momirova Valerija   Rouse Dwight J.   Caritis Steve N.   Peaceman Alan M.   Sciscione Anthony   Varner Michael W.   Malone Fergal D.   Mercer Brian M.   Thorp John M.   Sorokin Yoram   Carpenter Marshall W.   Lo Julie   Ramin Susan M.   Harper Margaret   Spong Catherine Y.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, Iss. 12, 2010-12 ,pp. : 1360-1364

Informa Healthcare

Access to resources Recommend Favorite

Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice

By Rebarber Andrei   Fox Nathan S.   Klauser Chad K.   Istwan Niki B.   Rhea Debbie J.   Stanziano Gary J.   Saltzman Daniel H.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, Iss. 10, 2010-10 ,pp. : 1139-1142

Informa Healthcare

Access to resources Recommend Favorite

Embryo-fetal toxicity signals for 17α-hydroxyprogesterone caproate in high-risk pregnancies: A review of the non-clinical literature for embryo-fetal toxicity with progestins

By Christian M. S.   Brent R. L.   Calda P.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 20, Iss. 2, 2007-01 ,pp. : 89-112

Informa Healthcare

Access to resources Recommend Favorite